Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Clinical trial NCT04507906 · COMPLETED
Trial details
- NCT number
- NCT04507906
- Sponsor
- Shanghai Chest Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-02
- Primary completion
- 2022-03-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.